Business Context and Reporting Period
This Form 8-K filing by American Water Works Company, Inc. (AWK) reports a regulatory event dated February 24, 2022. The filing concerns a general rate case decision by the Public Service Commission of West Virginia (PSC) affecting the Company's West Virginia subsidiary.
Key Financial Metrics
The filing details specific financial authorizations related to the West Virginia rate case rather than consolidated company-wide financial statements.
- Authorized Incremental Revenues: $14.8 million annualized.
- Excluded Reductions: $1.6 million for excess accumulated deferred income taxes and $10.2 million for infrastructure surcharges.
- Authorized Rate Base: $734.0 million.
- Authorized Return on Equity (ROE): 9.80%.
- Authorized Capital Structure: 47.97% equity component.
The filing text does not provide clear values for consolidated revenue, profit, cash flow, margins, debt, or liquidity for the reporting period.
Material Changes Versus Prior Period
The PSC order represents a material change in the authorized financial parameters for the West Virginia subsidiary compared to the prior general rate case effective in February 2019:
- ROE Increase: The authorized ROE increased from 9.75% to 9.80%.
- Rate Implementation: New rates became effective on February 25, 2022.
Guidance, Outlook, and Risks
The filing confirms the successful conclusion of a regulatory proceeding initiated on April 30, 2021. The outcome provides a defined revenue stream and rate base for the West Virginia operations. No specific forward-looking guidance, management commentary on broader risks, or unusual items were disclosed in this specific filing beyond the regulatory order details.
Investor Verification Checklist
- Verify the impact of the $14.8 million incremental revenue on the Company's consolidated earnings.
- Confirm the treatment of the $10.2 million infrastructure surcharges in future financial reporting.
- Review the full text of the West Virginia subsidiary press release (Exhibit 99.1) for operational details.
- Assess the significance of the 9.80% ROE authorization relative to the Company's overall cost of capital.